PubRank

W J Martin

Author PubWeight™ 374.73‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science 2000 15.16
2 In vitro antimicrobial susceptibility of anaerobic bacteria isolated from clinical specimens. Antimicrob Agents Chemother 1972 11.05
3 Evaluation of accuracy of multitest micromethod system for identification of Enterobacteriaceae. Appl Microbiol 1971 10.28
4 Detection of human papilloma virus in paraffin-embedded tissue using the polymerase chain reaction. J Exp Med 1988 9.10
5 Clinical utility of thoracoscopy. Chest 1992 6.34
6 Practical method for isolation of anerobic bacteria in the clinical laboratory. Appl Microbiol 1971 5.45
7 Identification of members of the family Enterobacteriaceae by the R-B system. Appl Microbiol 1970 5.27
8 Comparison of three blood culture media for recovery of anaerobic bacteria. Appl Microbiol 1973 5.22
9 Anaerobic bacteremia. Mayo Clin Proc 1972 4.79
10 Microwave oven for melting laboratory media. J Clin Microbiol 1978 4.33
11 Collaborative investigation of the AutoMicrobic System Enterobacteriaceae biochemical card. J Clin Microbiol 1980 4.28
12 Evaluation of reagent-impregnated strips for identification of Enterobacteriaceae. Am J Med Technol 1971 3.60
13 Isolation and indentification of anaerobic bacteria in the clinical laboratory. A 2-year experience. Mayo Clin Proc 1974 3.54
14 Detection of cytomegalovirus DNA in peripheral blood of patients infected with human immunodeficiency virus. J Infect Dis 1988 3.52
15 Cell to cell interaction in the immune response. IV. Site of action of antilymphocyte globulin. J Exp Med 1968 3.16
16 Klebsiella in faecal flora of renal-transplant patients. Lancet 1970 3.14
17 Evaluation of the enterotube system for identification of members of the family Enterobacteriaceae. Appl Microbiol 1971 3.11
18 Evaluation of enrichment, storage, and age of blood agar medium in relation to its ability to support growth of anaerobic bacteria. J Clin Microbiol 1976 3.09
19 Linkage between the poly-L-lysine gene and the locus controlling the major histocompatibility antigens in strain 2 guinea pigs. Proc Natl Acad Sci U S A 1970 2.89
20 Biochemical and clinical characteristics and antibiotic susceptibility of atypical Enterobacter cloacae. Appl Microbiol 1969 2.87
21 Pneumocystis carinii pneumonia. Differences in lung parasite number and inflammation in patients with and without AIDS. Am Rev Respir Dis 1989 2.86
22 Evaluation of the Auxotab Enteric 1 System for identification of Enterobacteriaceae. Appl Microbiol 1972 2.85
23 In vitro studies of piperacilin, a new semisynthetic penicillin. Antimicrob Agents Chemother 1978 2.82
24 Clinical isolation of Yersinia enterocolitica: cold temperature enrichment. J Clin Microbiol 1975 2.76
25 Genetic control of immune responsiveness to a glutamic acid, alanine, tyrosine copolymer in mice. I. Linkage of responsiveness to H-2 genotype. J Immunol 1971 2.60
26 API and Minitek systems in identification of clinical isolates of anaerobic gram-negative bacilli and Clostridium species. J Clin Microbiol 1979 2.54
27 Coagulase-negative staphylococcal bacteremia in patients receiving immunosuppressive therapy. Arch Intern Med 1983 2.53
28 Epidemiologic significance of Klebsiella pneumoniae. A 3-month study. Mayo Clin Proc 1971 2.51
29 Prevalence of serotypes of Salmonella. Appl Microbiol 1969 2.50
30 Clinical and bacteriologic studies of anaerobic gram-positive cocci. Mayo Clin Proc 1972 2.48
31 Diverticula of the Small Bowel. Ann Surg 1934 2.44
32 Heamophilus vaginalis (Corynebacterium vaginal): method for isolation and rapid biochemical identification. Health Lab Sci 1977 2.37
33 Bacteroides bacteremia. Minn Med 1970 2.36
34 Bacterial (suppurative) arthritis in the adult. J Bone Joint Surg Am 1970 2.26
35 Evaluation of the MS-2 system for rapid identification of Enterobacteriaceae. J Clin Microbiol 1980 2.26
36 Rapid identification and antimicrobial susceptibility testing of gram-negative bacilli from blood cultures by the AutoMicrobic system. J Clin Microbiol 1981 2.24
37 Comparative in vitro activity of moxalactam, cefotaxime, cefoperazone, piperacillin, and aminoglycosides against gram-negative bacilli. Antimicrob Agents Chemother 1980 2.23
38 Markedly decreased expression of class I histocompatibility antigens, protein, and mRNA in human small-cell lung cancer. J Exp Med 1985 2.12
39 Clinical evaluation of a lysis-centrifugation technique for the detection of septicemia. JAMA 1983 2.12
40 Analysis of DNA sequences in forty-year-old paraffin-embedded thin-tissue sections: a bridge between molecular biology and classical histology. Cancer Res 1988 2.06
41 Rapid detection of cytomegalovirus in bronchoalveolar lavage specimens by a monoclonal antibody method. J Clin Microbiol 1986 2.05
42 Comparison of rates of virus isolation from leukocyte populations separated from blood by conventional and Ficoll-Paque/Macrodex methods. J Clin Microbiol 1979 2.04
43 Hemagglutinin-specific cytotoxic T-cell response during influenza infection. J Exp Med 1977 1.97
44 Clinical evaluation of the AutoMicrobic system Yeast Biochemical Card for rapid identification of medically important yeasts. J Clin Microbiol 1981 1.94
45 Histocompatibility type and immune responsiveness in random bred Hartley strain guinea pigs. J Exp Med 1970 1.90
46 Gram-negative rod bacteremia: microbiologic, immunologic, and therapeutic considerations. Ann Intern Med 1977 1.90
47 Brain abscess with Corynebacterium hemolyticum: report of a case. Am J Clin Pathol 1971 1.87
48 Non-radioactive single strand conformation polymorphism (SSCP) using the Pharmacia 'PhastSystem'. Nucleic Acids Res 1991 1.86
49 Nosocomially acquired bacteriuria due to Proteus rettgeri and Providencia stuartii. Am J Clin Pathol 1973 1.83
50 Serratia marcescens. Biochemical characteristics, antibiotic susceptibility patterns, and clinical significance. JAMA 1970 1.80
51 In vitro susceptibility of gram-negative bacilli to gentamicin. Mayo Clin Proc 1970 1.72
52 Cell-adhesive motif in region II of malarial circumsporozoite protein. Science 1990 1.69
53 An analgesia circuit activated by cannabinoids. Nature 1998 1.68
54 Anti-Salmonella agglutinins in chronic active liver disease. Lancet 1971 1.67
55 Expression of yeast apurinic/apyrimidinic endonuclease (APN1) protects lung epithelial cells from bleomycin toxicity. Am J Respir Cell Mol Biol 2001 1.63
56 In vitro studies with netilmicin compared with amikacin, gentamicin, and tobramycin. Antimicrob Agents Chemother 1977 1.60
57 Enhanced immunogenicity of chemically-coated syngeneic tumor cells. Proc Natl Acad Sci U S A 1971 1.55
58 120-kD surface glycoprotein of Pneumocystis carinii is a ligand for surfactant protein A. J Clin Invest 1992 1.53
59 Specificity studies on cytotoxic thymus-derived lymphocytes reactive with influenza virus-infected cells: evidence for dual recognition of H-2 and viral hemagglutinin antigens. Proc Natl Acad Sci U S A 1977 1.53
60 In vitro susceptibility of staphylococci and streptococci and influence of agar media on minimum inhibitory concentration. Mayo Clin Proc 1970 1.53
61 Clinical and bacteriologic observations on the proposed species, Enterobacter agglomerans (the Herbicola-Lathyri bacteria). Mayo Clin Proc 1972 1.52
62 Effects of medium and inoculum on antimicrobial susceptibility of anaerobic bacteria. Am J Clin Pathol 1974 1.52
63 Site of action of antilymphocyte globulin. Lancet 1967 1.51
64 Neutrophils kill pulmonary endothelial cells by a hydrogen-peroxide-dependent pathway. An in vitro model of neutrophil-mediated lung injury. Am Rev Respir Dis 1984 1.50
65 Infections caused by Klebsiella ozaenae: a changing disease spectrum. J Clin Microbiol 1978 1.50
66 Comparative in vitro synergistic activity of new beta-lactam antimicrobial agents and amikacin against Pseudomonas aeruginosa and Serratia marcescens. Antimicrob Agents Chemother 1981 1.49
67 Detection of human papillomavirus in normal and dysplastic tissue by the polymerase chain reaction. Lab Invest 1988 1.48
68 Interaction of vitronectin with Pneumocystis carinii: evidence for binding via the heparin binding domain. J Lab Clin Med 1995 1.48
69 Cell-to-cell interaction in the immune response. VII. Requirement for differentiation of thymus-derived cells. J Exp Med 1971 1.46
70 Oxidant injury of lung parenchymal cells. J Clin Invest 1981 1.44
71 Recent Trends of Some Infectious Diseases. Br Med J 1942 1.44
72 Simplified method of anaerobic incubation. Appl Microbiol 1971 1.44
73 Cytomegalovirus infections associated with leukocyte transfusions. Ann Intern Med 1980 1.44
74 Functional impairment of bronchoalveolar lavage phospholipids in early Pneumocystis carinii pneumonia in rats. J Lab Clin Med 1996 1.41
75 Serum levels of interleukin-2 receptor and activity of rheumatic diseases characterized by immune system activation. Arthritis Rheum 1988 1.41
76 Comparison of the Minitek test system with a conventional screening procedure for identification of Enterobacteriaceae. Health Lab Sci 1978 1.40
77 Detection of human papillomavirus in formalin-fixed, invasive squamous carcinomas using the polymerase chain reaction. Am J Surg Pathol 1989 1.40
78 Isolation of Plasmodium berghei (malaria) parasites by ammonium chloride lysis of infected erythrocytes. Nat New Biol 1971 1.38
79 Role of fibronectin in Pneumocystis carinii attachment to cultured lung cells. J Clin Invest 1990 1.37
80 Rapid characterization of salmonella organisms by means of pyrolysis-gas-liquid chromatography. Anal Chem 1972 1.35
81 Pneumocystis carinii: inhibition of lung cell growth mediated by parasite attachment. J Clin Invest 1990 1.33
82 In vitro antibacterial activity of minocycline and effect of agar medium utilized in its susceptibility testing. Appl Microbiol 1970 1.30
83 Yersinia enterocolitica: in vitro antimicrobial susceptibility. Antimicrob Agents Chemother 1978 1.30
84 Fungal endophthalmitis following intraocular lens implantation. A surgical epidemic. Arch Ophthalmol 1980 1.30
85 Pneumocystis carinii attachment to cultured lung cells by pneumocystis gp 120, a fibronectin binding protein. J Clin Invest 1991 1.29
86 Comparison of media for isolation of salmonellae and shigellae from fecal specimens. Appl Microbiol 1971 1.29
87 Assay for the immunosuppressive capacity of antilymphocyte serum. I. Evidence for opsonization. J Immunol 1969 1.28
88 Hydrogen sulfide-negative variant of Citrobacter. Appl Microbiol 1970 1.27
89 Comparison of Enteric-Tek with API 20E and conventional methods for identification of Enterobacteriaceae. J Clin Microbiol 1982 1.24
90 The deoxyribonuclease test as applied to certain gram-negative bacteria. Can J Microbiol 1967 1.23
91 Influenza A viruses of the H2N2 subtype are lymphocyte mitogens. Nature 1978 1.20
92 Genetically engineered macrophages expressing IFN-gamma restore alveolar immune function in scid mice. Proc Natl Acad Sci U S A 2001 1.20
93 Identification and characterization of novel mammalian neuropeptide FF-like peptides that attenuate morphine-induced antinociception. J Biol Chem 2001 1.20
94 Mechanism of Pneumocystis carinii attachment to cultured rat alveolar macrophages. J Clin Invest 1990 1.17
95 Assay for the immunosuppressive capacity of antilymphocyte serum based on its action on thymus-derived cells. Int Arch Allergy Appl Immunol 1969 1.15
96 DNA of human papillomavirus type 16 in dysplastic and malignant lesions of the conjunctiva and cornea. N Engl J Med 1989 1.14
97 Comparison of the BACTOMETER microbial monitoring system with conventional methods for detection of microorganisms in urine specimens. J Clin Microbiol 1977 1.13
98 Interstitial lung disease. Assessment by bronchoalveolar lavage. Mayo Clin Proc 1983 1.12
99 Immune surveillance directed against depressed cellular and viral alloantigens. Cell Immunol 1975 1.11
100 Surfactant protein a promotes attachment of Mycobacterium tuberculosis to alveolar macrophages during infection with human immunodeficiency virus. Proc Natl Acad Sci U S A 1995 1.10
101 Cytotoxic T lymphocytes induced in mice by inactivated influenza virus vaccine. Nature 1977 1.09
102 Interspecies brain antigen detected by naturally occurring mouse anti-brain autoantibody. Proc Natl Acad Sci U S A 1975 1.09
103 Surfactant protein A (SP-A) mediates attachment of Mycobacterium tuberculosis to murine alveolar macrophages. Am J Respir Cell Mol Biol 1997 1.08
104 Anaerobic bacteria in the urinary tract. Mayo Clin Proc 1972 1.06
105 Thymus reactive IgM autoantibodies in normal mouse sera. Nature 1975 1.06
106 Anaerobic and aerobic bacteriology of acute conjunctivitis. Ann Ophthalmol 1979 1.05
107 Murine laminin binds to Histoplasma capsulatum. A possible mechanism of dissemination. J Clin Invest 1995 1.05
108 Relation of pyrogenic and emetic properties of enterobacteriaceal endotoxin and of staphylococcal enterotoxin. J Bacteriol 1964 1.04
109 Anti-tumour antibodies in normal mouse sera. Int J Cancer 1975 1.03
110 Serum-mediated immunological non-reactivity between histoincompatible cells in tetraparental mice. Nature 1971 1.03
111 The neurobiology of cannabinoid analgesia. Life Sci 1999 1.02
112 Measles in West Africa. West Afr Med J Niger Pract 1967 1.02
113 Derepressed alloantigen in transplacentally induced lung tumor coded for by H-2 linked gene. Science 1976 1.02
114 The effects of sinus bacteria on human ciliated nasal epithelium in vitro. Otolaryngol Head Neck Surg 1988 1.02
115 Clinical evaluation of the improved streptex method for grouping streptococci. Diagn Microbiol Infect Dis 1984 1.02
116 Naturally occurring cytotoxic anti-tumour antibodies in sera of congenitally athymic (nude) mice. Nature 1974 1.01
117 Modulation of Pneumocystis carinii adherence to cultured lung cells by a mannose-dependent mechanism. J Lab Clin Med 1991 1.01
118 Comparison of media for isolation of Ureaplasma urealyticum and genital Mycoplasma species. J Clin Microbiol 1984 1.00
119 Extrahepatic expression of the N-acetylation polymorphism toward arylamine carcinogens in tumor target organs of an inbred rat model. J Pharmacol Exp Ther 1991 1.00
120 Measles in East and Central Africa. East Afr Med J 1967 0.99
121 Mapping alveolar binding sites in vivo using phage peptide libraries. Gene Ther 2003 0.99
122 Evaluation of modified R-B system for identification of members of the family Enterobacteriaceae. Appl Microbiol 1972 0.98
123 Nitrofurantoin. Potential direct and indirect mechanisms of lung injury. Chest 1983 0.97
124 Pathogenesis and host response in Pneumocystis carinii pneumonia. Annu Rev Med 1994 0.95
125 Two additional Salmonella serotypes. Salmonella enteritidis ser 58:a:- and Salmonella enteritidis ser 44:z36, z38:-. Appl Microbiol 1969 0.94
126 Naturally occurring cytotoxic tumour reactive antibodies directed against type C viral envelope antigens. Nature 1975 0.94
127 Relative opsonic and protective activities of antibodies against K1, O and lipid A antigens of Escherichia coli. Scand J Infect Dis 1979 0.94
128 Oxidant-mediated ciliary dysfunction. Possible role in airway disease. Chest 1986 0.93
129 The cellular basis of immunological tolerance in newborn animals. Aust J Exp Biol Med Sci 1966 0.93
130 Reduction of BCNU toxicity to lung cells by high-level expression of O(6)-methylguanine-DNA methyltransferase. Am J Physiol Lung Cell Mol Physiol 2001 0.93
131 Cardiopulmonary resuscitation skills. Do we expect too much? Arch Intern Med 1984 0.93
132 Gamma interferon stimulates rat alveolar macrophages to kill Pneumocystis carinii by L-arginine- and tumor necrosis factor-dependent mechanisms. Infect Immun 1999 0.93
133 Inhibition of noxious stimulus-evoked activity of spinal cord dorsal horn neurons by the cannabinoid WIN 55,212-2. Life Sci 1995 0.93
134 Treating severe metabolic alkalosis. Clin Pharm 1983 0.92
135 Surfactant protein A suppresses reactive nitrogen intermediates by alveolar macrophages in response to Mycobacterium tuberculosis. J Clin Invest 1999 0.92
136 Newer penicillins. Med Clin North Am 1967 0.92
137 Interlobar variation in the recovery of bronchoalveolar lavage fluid, cell populations, and angiotensin-converting enzyme in normal volunteers. J Lab Clin Med 1993 0.92
138 Recovery of anaerobic bacteria from pediatric patients. A one-year experience. Am J Dis Child 1979 0.92
139 Nitrated SP-A does not enhance adherence of Pneumocystis carinii to alveolar macrophages. Am J Physiol 1998 0.92
140 Enhanced cytotoxic potential of alveolar macrophages from cigarette smokers. J Lab Clin Med 1988 0.92
141 Molecular characterization of the C3HfB/HeN H-2Kkm2 mutation. Implications for the molecular basis of alloreactivity. J Exp Med 1988 0.91
142 Human papillomavirus DNA in a recurrent squamous carcinoma of the eyelid. Arch Ophthalmol 1989 0.91
143 Clinical laboratory applications of monoclonal antibodies. Clin Microbiol Rev 1988 0.91
144 Bacteriology and in vitro antimicrobial susceptibility of the Pseudomonas fluorescens group isolated from clinical specimens. Am J Clin Pathol 1973 0.91
145 Bronchoalveolar lavage fluid angiotensin-converting enzyme in interstitial lung diseases. Am Rev Respir Dis 1990 0.91
146 Comparative in vitro susceptibility of yeasts to amphotericin B and three methyl ester derivatives. Antimicrob Agents Chemother 1981 0.91
147 Clathrin-coated pit-associated proteins are required for alveolar macrophage phagocytosis. J Immunol 1999 0.91
148 Aminoglycosides in the treatment of bacteraemic infections in the immuno-comprised host. J Antimicrob Chemother 1981 0.91
149 Suppression of noxious stimulus-evoked expression of Fos protein-like immunoreactivity in rat spinal cord by a selective cannabinoid agonist. Neuroscience 1996 0.90
150 Detoxified bacterial endotoxins. I. Preparation and biological properties of an acetylated crude endotoxin from Salmonella typhimurium. J Bacteriol 1966 0.90
151 Cyclophosphamide-induced lung toxicity: mechanism of endothelial cell injury. J Pharmacol Exp Ther 1994 0.90
152 Bacteriology of tracheal aspirates in intubated newborn. Chest 1980 0.89
153 Assessment of in vivo attachment/phagocytosis by alveolar macrophages. J Immunol Methods 1996 0.89
154 Aerobic and anaerobic bacteriology of perirectal abscess in children. Pediatrics 1980 0.89
155 Histocompatibility genes, immune responsiveness, and leukaemia. Lancet 1970 0.89
156 Pulmonary disease in polymyositis/dermatomyositis: a clinicopathological analysis of 65 autopsy cases. Ann Rheum Dis 1987 0.88
157 Vitronectin protects alveolar macrophages from silica toxicity. Am J Respir Crit Care Med 2000 0.88
158 The rodent amygdala contributes to the production of cannabinoid-induced antinociception. Neuroscience 2003 0.88
159 Detection of human cytomegalovirus in ocular tissue by polymerase chain reaction and in situ DNA hybridization. Graefes Arch Clin Exp Ophthalmol 1993 0.88
160 Incomplete hydrolysis of the calcium indicator precursor fura-2 pentaacetoxymethyl ester (fura-2 AM) by cells. Anal Biochem 1988 0.88
161 Human surfactant protein A enhances attachment of Pneumocystis carinii to rat alveolar macrophages. Am J Respir Cell Mol Biol 1996 0.87
162 Acetylator phenotype-dependent and -independent expression of arylamine N-acetyltransferase isozymes in rapid and slow acetylator inbred rat liver. Drug Metab Dispos 1992 0.87
163 H-2a-associated alloantigen expressed by several transplacentally-induced lung tumours of C3Hf mice. Nature 1977 0.87
164 Lung infections: role of apoptosis in host defense and pathogenesis of disease. Chest 2000 0.87
165 Effect of Klebsiella ozaenae on ciliary activity in vitro: implications in the pathogenesis of atrophic rhinitis. Otolaryngol Head Neck Surg 1990 0.86
166 Role of bronchoalveolar lavage in the assessment of opportunistic pulmonary infections: utility and complications. Mayo Clin Proc 1987 0.86
167 Bleomycin-induced pulmonary endothelial cell injury: evidence for the role of iron-catalyzed toxic oxygen-derived species. J Lab Clin Med 1987 0.85
168 Biochemical comparison of H-2K antigen isolated from C3HfB/HeN and C3H/HeN mice. Immunogenetics 1981 0.85
169 Fluorescent liposomes as quantitative markers of phagocytosis by alveolar macrophages. J Immunol Methods 1995 0.85
170 The isolation of rat alveolar type II cells: a simplified approach using Percoll density centrifugation. Lung 1984 0.84
171 Chronic osteomyelitis. I. Factors affecting the results of treatment in 186 patients. JAMA 1970 0.84
172 Nitrofurantoin-stimulated oxidant production in pulmonary endothelial cells. J Lab Clin Med 1985 0.84
173 Anaerobic bacteremia in children. Am J Dis Child 1980 0.84
174 Assay for the immunosuppressive capacity of antilymphocyte serum. 3. Opsonizing activity of anti-human lymphocyte serum. J Immunol 1969 0.84
175 Bacteremia due to gram-negative bacilli. Clinical and autopsy findings in 33 cases. Am J Clin Pathol 1968 0.84
176 Detoxified bacterial endotoxns. II. Preparation and biological properties of chemically modified crude endotoxins from Salmonella typhimurium. J Bacteriol 1966 0.84
177 Detection of human papillomavirus DNA in fine-needle aspirations of metastatic squamous-cell carcinoma of the uterine cervix using the polymerase chain reaction. Diagn Cytopathol 1989 0.83
178 Reduction of neutrophil-mediated injury to pulmonary endothelial cells by dapsone. Am Rev Respir Dis 1985 0.83
179 Lung tumor-associated derepressed alloantigen coded for by the K region of the H-2 major histocompatibility complex. J Exp Med 1978 0.83
180 Paraquat-induced injury of type II alveolar cells. An in vitro model of oxidant injury. Am Rev Respir Dis 1984 0.83
181 Alpha-1-antitrypsin expression in the lung is increased by airway delivery of gene-transfected macrophages. Gene Ther 2003 0.83
182 Evidence for Pneumocystis carinii binding to a cell-free substrate: role of the adhesive protein fibronectin. J Lab Clin Med 1994 0.83
183 Isolation of an obligately anaerobic Streptococcus pneumoniae from blood culture. J Clin Microbiol 1977 0.82
184 Chronic osteomelitis. II. Treatment with closed irrigation and suction. JAMA 1970 0.82
185 Intravenous tubing containing burettes can be safely changed at 72 hour intervals. Infect Control 1987 0.82
186 Induction of angiotensin converting enzyme in cultured human monocytes by a factor present in the bronchoalveolar lavage fluid of sarcoidosis patients. Sarcoidosis 1988 0.82
187 Acquired methemoglobinemia from multiple oxidants. South Med J 1993 0.82
188 Expression by human neuroblastoma cells of an antigen recognized by naturally occurring mouse anti-brain autoantibody. Cancer Res 1975 0.82
189 Common tumor-associated transplantation alloantigen detected on a proportion of lung tumors induced transplacentally in several strains of mice. Transplantation 1977 0.81
190 Identification of a T-cell epitope on the circumsporozoite protein of Plasmodium vivax. Infect Immun 1990 0.81
191 Tobacco additives and cigarette smoke. II. Organic, gas-phase products from D-glucose and sucrose. Carbohydr Res 1971 0.81
192 CPR skills: achievement and retention under stringent and relaxed criteria. Am J Public Health 1983 0.81
193 Suppressed development of cytotoxic lymphoid cells in tumor-immunized mice. Isr J Med Sci 1973 0.81
194 Rapid and reliable techniques for the laboratory detection of bacterial meningitis. Am J Med 1983 0.81
195 Evidence for the suppression of the development of cytotoxic lymphoid cells in tumor immunized mice. Fed Proc 1973 0.81
196 Assay for the immunosuppressive capacity of antilymphocyte serum. II. Nature and specificity of opsonizing antibody. J Immunol 1969 0.81
197 Prophylaxis of recurrent lymphangitis complicating lymphedema. JAMA 1966 0.81
198 Distinct recognition of influenza virus hemagglutinin and H-2 antigens by cytotoxic thymus derived lymphocytes. Dev Biol Stand 1978 0.81
199 Effect of silver nitrate application on the conjunctival flora of the newborn: and the occurrence of clostridial conjunctivitis. J Pediatr Ophthalmol Strabismus 1979 0.80
200 Modified agar dilution method for rapid antibiotic susceptibility testing of anaerobic bacteria. Antimicrob Agents Chemother 1978 0.80
201 Cryopreservation of canine trachea: functional and histological changes. Ann Thorac Surg 1989 0.80
202 Immunization of neonatal rabbits with bovine serum albumin associated with allogeneic thymus cells. Immune response and allotypic markers of antibody. Int Arch Allergy Appl Immunol 1971 0.80
203 In-vitro studies with ceftazidime against aerobic gram-negative bacilli and Bacteroides fragilis group. J Antimicrob Chemother 1981 0.80
204 Amiodarone-induced injury of human pulmonary artery endothelial cells: protection by alpha-tocopherol. J Pharmacol Exp Ther 1990 0.79
205 Immunological distinction between ribonuclease H activity of alpha and alph beta forms of avian myeloblastosis virus (AMV) DNA polymerase. Virology 1977 0.79
206 Abnormal interaction of alpha 1-antitrypsin and leukocyte elastolytic activity in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1979 0.79
207 Antilymphoblast globulin in renal transplant patients. No allergic reactions. JAMA 1976 0.79
208 Depression of alloantigens in malignancy. Evidence for tumour susceptibility alloantigens and for possible self-reactivity of lymphoid cells active in the microcytotoxicity assay. Br J Cancer Suppl 1973 0.79
209 Acetylator genotype-dependent N-acetylation of arylamines in vivo and in vitro by hepatic and extrahepatic organ cytosols of Syrian hamsters congenic at the polymorphic acetyltransferase locus. Arch Toxicol 1992 0.79
210 Aerobic and anaerobic bacterial flora of the maternal cervix and newborn gastric fluid and conjunctiva: a prospective study. Pediatrics 1979 0.79
211 Isolation of Pneumocystis carinii gp120 by fibronectin affinity: evidence for manganese dependence. Am J Respir Cell Mol Biol 1994 0.78
212 Biochemical evidence for expression of a semi-allogeneic, H-2 antigen by a murine adenocarcinoma. J Immunol 1983 0.78
213 Amiodarone-mediated increase in intracellular free Ca2+ associated with cellular injury to human pulmonary artery endothelial cells. Toxicol Appl Pharmacol 1990 0.78
214 Differential diagnostic significance of the paucity of HLA-I antigens on metastatic breast carcinoma cells in effusions. Pathol Oncol Res 1999 0.78
215 Heights and weights of West African village children from birth to the age of five. West Afr Med J Niger Pract 1968 0.78
216 Amiodarone-induced lung toxicity. In vitro evidence for the direct toxicity of the drug. Am J Pathol 1985 0.78
217 Surgical management of neurotrophic ulcers in the diabetic foot. J Am Podiatry Assoc 1975 0.78
218 Nitrofurantoin: evidence for the oxidant injury of lung parenchymal cells. Am Rev Respir Dis 1983 0.77
219 Repeat subculture of known positive blood cultures: costly and ineffective in detecting polymicrobial bacteremias. Diagn Microbiol Infect Dis 1985 0.77
220 Musculoskeletal infections due to bacteroides. J Bone Joint Surg Am 1969 0.77
221 Lung tumor-reactive cytotoxic lymphocytes generated in mixed lymphocyte reaction between C3HfeB/HeN (H-2kb) and C3H/HeN (H-2k) strain mice. J Immunol 1979 0.77
222 Surfactant protein A prevents silica-mediated toxicity to rat alveolar macrophages. Am J Physiol Lung Cell Mol Physiol 2000 0.77
223 Polymerase chain reaction heteroduplex polymorphism analysis by entangled solution capillary electrophoresis. J Chromatogr A 1994 0.77
224 Cytomegalovirus infection with idiopathic pulmonary fibrosis. Diagnosis suggested by bronchoalveolar lavage. Chest 1983 0.77
225 Bacterial colonization in intubated newborns. Respiration 1980 0.77
226 Measles in Nigerian children: A study of the disease in West Africa, and its manifestations in England and other countries during different epochs. J Hyg (Lond) 1963 0.77
227 The pharmacokinetics of cimetidine and metabolites in a neonate. Drug Intell Clin Pharm 1985 0.77
228 Histocompatibility difference between C3HfeB/HeN and C3H/HeN mice: tumour induced in C3HfeB/HeN mice expresses C3H/HeN-associated alloantigen. J Immunogenet 1978 0.77
229 Nature of fecal sterols and intestinal bacterial flora. Lipids 1973 0.77
230 Pneumocystis carinii pneumonia and pulmonary surfactant. J Lab Clin Med 1999 0.76
231 Paraquat-induced neutrophil alveolitis: reduction of the inflammatory response by pretreatment with endotoxin and hyperoxia. Lung 1986 0.76
232 In vitro effect of human lymphotoxin on microorganisms. Mayo Clin Proc 1973 0.76
233 In vivo pharmacological characterization of TD-4208, a novel lung-selective inhaled muscarinic antagonist with sustained bronchoprotective effect in experimental animal models. J Pharmacol Exp Ther 2013 0.76
234 Mortality in Childhood during 1920-38. Br Med J 1945 0.76
235 Inhibition of human immunodeficiency virus-1 proliferation by liposome-encapsulated sense DNA to the 5' tat splice acceptor site. Antisense Res Dev 1992 0.76
236 Mechanism of putrescine transport in human pulmonary artery endothelial cells. J Pharmacol Exp Ther 1993 0.76
237 Intravenous tubing with burettes can be safely changed at 48-hour intervals. JAMA 1984 0.76
238 Variation in expression of H-2 histocompatibility antigens on tumor cells. Transplant Proc 1980 0.76
239 Chronic fatigue syndrome. Science 1992 0.75
240 New Salmonella serotype: Salmonella enteritidis ser. Ordonez. Appl Microbiol 1969 0.75
241 Diphtheria: A suggested explanation of the relative change in age incidence. J Hyg (Lond) 1939 0.75
242 Comparison of radioimmunoassay with a new immunofluorescent method (FIAX) for measuring tobramycin in serum. Antimicrob Agents Chemother 1982 0.75
243 Suppression of experimental uveitis in rats by anti-I-A antibodies. Invest Ophthalmol Vis Sci 1989 0.75
244 Undescribed serotype of Salmonella: Salmonella enteritidis ser. Lovelace. Appl Microbiol 1970 0.75
245 Physical type in pneumoconiosis. J Hyg (Lond) 1941 0.75
246 Amiodarone pulmonary toxicity. Intensive Care Med 1992 0.75
247 Pharmacokinetics and pharmacodynamics of cimetidine and metabolites in critically ill children. J Pediatr 1985 0.75
248 Clinical evaluation of the Lumac bioluminescence method for screening urine specimens. J Clin Microbiol 1985 0.75
249 Exercise impairment in asbestos-induced pleural fibrosis. Is it really just interstitial fibrosis? Chest 1994 0.75
250 Tobacco additives and cigarette smoke. I. Transfer of D-glucose, sucrose, and their degradation products to the smoke. Carbohydr Res 1971 0.75
251 Disparities in assessment of disease activity. Chest 1989 0.75
252 Mechanisms of drug-induced lung disease. J Lab Clin Med 1993 0.75
253 Diagnostic bronchoalveolar lavage in immunosuppressed patients with new pulmonary infiltrates. Mayo Clin Proc 1992 0.75
254 Salmonella enteritidis serotype 50-1,2,3: Z4, Z24:-. Appl Microbiol 1970 0.75
255 Chronic nitrofurantoin reaction associated with T-lymphocyte alveolitis. Chest 1986 0.75
256 Infections of the urinary tract. Clin Obstet Gynecol 1967 0.75
257 "How I do it" - head and neck. A targeted problem and its solution. Bronchoscopy as an aid in the diagnosis of pneumonia in pediatric immunosuppressed patients. What to order. Laryngoscope 1981 0.75
258 Bacteremia due to Gram-negative bacilli. Some current concepts of therapy. Part I. Minn Med 1967 0.75
259 Microvesicle-induced antigen transfer to target cell membranes. Transplant Proc 1980 0.75
260 X chromosome-linked defect of CBA/HN mice in production of tumor-reactive naturally occurring IgM antibodies. J Immunol 1975 0.75
261 A retrospective analysis of heel pain. J Am Podiatr Med Assoc 1985 0.75
262 Experimental studies relating to the production and clinical testing of anti-human lymphocyte serum. Med J Aust 1969 0.75
263 Transmission of Internal Cork of Sweet Potato by the Cotton Aphid, Aphis gossypii Glover. Science 1958 0.75
264 Patient education on cancer chemotherapeutic agents. Am Pharm 1983 0.75
265 Immune response of mice to concanavalin A-coated EL 4 leukemia. Natl Cancer Inst Monogr 1972 0.75
266 Performance characteristics of three serum iron and total iron-binding capacity methods in acute iron overdose. Am J Clin Pathol 1999 0.75
267 Storage-dispenser device for food cubes aboard a space vehicle. SAM-TR-68-62. Tech Rep SAM-TR 1968 0.75
268 Cloxacillin for prophylaxis in oral surgery. Minn Med 1967 0.75
269 Ampicillin administered prophylactically in oral surgery. Northwest Dent 1972 0.75
270 Nafcillin for prophylaxis in oral surgery. Minn Med 1968 0.75
271 Functional efficiency of antitumor cytotoxic lymphoid cells. Isr J Med Sci 1973 0.75
272 Biochemical comparison of MHC antigens isolated from mutant C3HfB/HeN and parent C3H/HeN mice. J Immunol 1982 0.75
273 Antibacterial management of infection due to gram-negative bacilli. Minn Med 1966 0.75
274 Search for type-C oncornavirus-related genetic information in tissues from patients with systemic lupus erythematosus. Arthritis Rheum 1979 0.75
275 Determination of cimetidine and metabolites in plasma by reversed-phase high-performance liquid chromatographic radial compression technique. J Chromatogr 1985 0.75
276 The sex ratio of pneumonia mortality. J Hyg (Lond) 1944 0.75
277 Endotoxic shock in obstetrics and gynecology. Minn Med 1968 0.75
278 The incidence of postoperative infection in outpatient podiatric surgery. J Am Podiatry Assoc 1984 0.75
279 Diptheria. The age incidence during epidemic years in London. J Hyg (Lond) 1942 0.75
280 Studies in the declining birth-rate, England and Wales: 1. The Northern Counties 2. Summary of Results for all Areas. J Hyg (Lond) 1937 0.75
281 Some medical aspects of the dental patient. J Am Dent Assoc 1967 0.75
282 Untoward reactions associated with antimicrobial therapy. I. Cardiovascular, respiratory, gastrointestinal, hematopoietic, and genitourinary reactions. Minn Med 1967 0.75
283 The semisynthetic penicillins. Minn Med 1967 0.75
284 Complications of antibiotic therapy in the management of bacterial infections. J Lancet 1966 0.75
285 The present status of streptomycin in antimicrobial therapy. Med Clin North Am 1970 0.75
286 Biochemical comparison of mutant H-2Kkvl (C3HfB/HeN) and parent H-2Kk (C3H/HeN) glycoproteins. Transplant Proc 1981 0.75
287 Atypical pseudocholinesterase. A case report. J Am Podiatr Med Assoc 1985 0.75
288 Use of soft heat-molded orthoses in sports. A clinical analysis. J Am Podiatr Med Assoc 1993 0.75
289 Endothelial-leukocyte adhesiveness. J Lab Clin Med 1988 0.75
290 Identification of Ia antigens on the murine adenocarcinoma LT-85. J Natl Cancer Inst 1983 0.75
291 Differential susceptibility of spleen cells from C3/HeN (H-2k) and C3HfB/HeN (H-2kv1) mouse strains to cytotoxicity by monoclonal anti-Kk antibody (clone 11-4). J Immunogenet 1981 0.75
292 The HCFA proposal for changes in Medicare practice expenses: need for legislative action. Am J Respir Crit Care Med 1997 0.75
293 Infections of the urinary tract. Med Clin North Am 1966 0.75
294 Variable expression and immunogenicity of an H-2K-coded alloantigen on murine tumours. J Immunogenet 1980 0.75
295 MHC-coded unique alloantigens and antitumor immunity. Transplant Proc 1981 0.75
296 Stealth virus isolated from an autistic child. J Autism Dev Disord 1995 0.75
297 Alcoholic hepatitis. Minn Med 1975 0.75
298 Prophylactic use of lincomycin in oral surgery. Minn Med 1969 0.75
299 Antibacterial management of infections due to gram-negative bacilli. IV. Principles of management, empiric therapy, and some infections of the respiratory tract. Minn Med 1966 0.75
300 Antibacterial management of infection due to gram-negative bacilli. VI. Some infections of the nervous system, skeletal system, hematopoietic system, skin, and soft tissues and comment. Minn Med 1966 0.75
301 Isolation of viruses from single throat swabs processed for diagnosis of group A beta-hemolytic streptococci by fluorescent antibody technic. Am J Clin Pathol 1973 0.75
302 Studies in the declining birth-rate, the Midlands and London. J Hyg (Lond) 1937 0.75
303 Bacteremic shock. Med Ann Dist Columbia 1967 0.75
304 Untoward reactions associated with antimicrobial therapy. 3. Metabolic and electrolytic, skeletal, neuromuscular, and dermal reactions with comment and conclusions. Minn Med 1967 0.75
305 The Epidemic Curve of Smallpox. J Hyg (Lond) 1934 0.75
306 Antibacterial management of infection due to gram-negative bacilli. 3. Use of ampicillin, the cephalosporins, spectinomycin, and chemotherapy. Minn Med 1966 0.75
307 Bacteremia due to gram-negative bacilli. Some current concepts. II. Minn Med 1967 0.75
308 Utility of bronchoalveolar lavage in the diagnosis of drug-induced pulmonary toxicity. Acta Cytol 1989 0.75
309 Nonimmune phagocytosis of liposomes by rat alveolar macrophages is enhanced by vitronectin and is vitronectin-receptor mediated. Am J Respir Cell Mol Biol 1997 0.75
310 Behavioral and genetic interrelationships between locomotor activity and brain biogenic amines. Gen Pharmacol 1990 0.75
311 Studies in the Declining Birth-rate, Wales and South England. J Hyg (Lond) 1936 0.75
312 Antibacterial management of infections due to gram-negative bacilli. II. Use of the teteracyclines, chloramphenicol, polymyxin B, cycloserine, and paromomycin. Surg Gynecol Obstet 1966 0.75
313 Bacteremia and bacteremic shock in surgical patients. Surg Clin North Am 1969 0.75
314 Paradox of brucellosis. Decreased incidence but increased difficulty in clinical recognition. Minn Med 1967 0.75
315 The Decrease in Mortality During Early Adult Male Life in England and Wales. J Hyg (Lond) 1935 0.75
316 [Antibiotic therapy of bacteriemia and bacterial endocarditis]. Rev Lyon Med 1969 0.75
317 Stability of morphine sulfate and meperidine hydrochloride in a parenteral nutrient formulation. Am J Hosp Pharm 1985 0.75
318 Tourniquet use in sickle cell disease patients. J Am Podiatry Assoc 1984 0.75
319 Recovery of anaerobic bacteria from vented blood-culture bottles. Rev Infect Dis 1984 0.75
320 Amiodarone pulmonary toxicity. Assessment by bronchoalveolar lavage. Chest 1985 0.75
321 The penicillins. J Lancet 1967 0.75
322 Oral surgery. Cloxacillin for prophylaxis. Minn Med 1971 0.75
323 An assay for virus-specific help for B cells. J Immunol Methods 1981 0.75
324 Functional capacity of cytotoxic lymphoid cells. Natl Cancer Inst Monogr 1972 0.75
325 Evidence that derivation of the adenocarcinoma LT85 predated establishment of the H-2km2 mutation in a C3Hf colony of mice. J Immunogenet 1990 0.75
326 Non-specific cytotoxic cells generated in vitro in response to a weakly immunogenic murine adenocarcinoma. In vivo correlations. Int J Cancer 1981 0.75
327 Normal tissue alloantigens and genetic control of susceptibility to tumors: microcytotoxicity studies on resistant C3Hf and susceptible (A X C3Hf) F1 mice inoculated with transplacentally induced C3Hf lung tumor. J Immunol 1975 0.75
328 Antibiotic therapy in the management of lymphangitis. Mod Treat 1969 0.75
329 Structural and functional alterations in H-2 antigen expression on tumor cells. Transplant Proc 1983 0.75
330 Erythromycin for prophylaxis prior to oral surgery in patients allergic to panicillin. Northwest Dent 1968 0.75
331 Clinical utility of bronchoalveolar lavage in the assessment of interstitial lung disease. Ann Otol Rhinol Laryngol 1983 0.75
332 Phthisis and Physical Measurements in Wales. J Hyg (Lond) 1936 0.75
333 Neonatal pneumonia caused by members of the Bacteroides fragilis group. Clin Pediatr (Phila) 1980 0.75
334 A preliminary analysis of fibular sesamoidectomy in the McBride bunionectomy. J Am Podiatry Assoc 1983 0.75
335 Importance of hydrogen peroxide in nitrofurantoin-induced cytotoxicity: evidence from an inbred catalase-deficient strain of mice. J Lab Clin Med 1988 0.75
336 Antigenic analysis of Shigella sonnei by gel diffusion technics. Can J Microbiol 1968 0.75
337 Variation in histocompatibility antigen expression on murine tumors: differences in expression and immunogenicity of H-2K region-coded unique antigens. J Immunol 1982 0.75
338 Antibacterial management of infections due to gram-negative bacilli. I. Introduction, pathogens, and use of streptomycin, dihydrostreptomycin, neomycin, kanamycin and gentamicin. Minn Med 1966 0.75
339 Unusual features of sterol excretion and distribution in the White Carneau pigeon. Biochem J 1972 0.75
340 Health-care reform and pulmonary/critical care medicine. A revolution with or without data. Chest 1995 0.75